New NIH chief stresses focus on obesity, clinical trial challenges
The new leader of the NIH is worried about obesity.
Monica Bertagnolli, who was confirmed as the new NIH director last week, said that during her first meeting with the NIH institute heads, she posed a question: “Is there anybody in this room who isn’t worried about obesity?”
“The answer is really no,” she told the Friends of Cancer Research annual meeting on Tuesday.
Her comments arrive as blockbuster GLP-1s have shown they can reduce major cardiovascular risks, among other benefits. Speaking alongside FDA Commissioner Robert Califf, Bertagnolli discussed clinical trials, declining life expectancy in the US, and the role of insurers in ensuring research gets carried out.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.